Inventor
SINGER CLAUDE
IL36 patents
⚠️ This page may combine multiple inventors who share the name “SINGER CLAUDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEVA PHARMA
27 patentsUS6365574B2Apr 2, 2002
Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
TEVA PHARMA59 citations96
US6500987B1Dec 31, 2002
Sertraline hydrochloride polymorphs
TEVA PHARMA38 citations95
US6255526B1Jul 3, 2001
Preparation of gabapentin
TEVA PHARMA58 citations95
US6600073B1Jul 29, 2003
Methods for preparation of sertraline hydrochloride polymorphs
TEVA PHARMA14 citations92
US6586576B2Jul 1, 2003
Preparation method of azithromycin hydrates
TEVA PHARMA21 citations92
US6452054B2Sep 17, 2002
Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
TEVA PHARMA36 citations92
US6531509B2Mar 11, 2003
Stable gabapentin containing more than 20 ppm of chlorine ion
TEVA PHARMA19 citations91
US6849120B2Feb 1, 2005
Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms
TEVA PHARMA24 citations90
US6764997B2Jul 20, 2004
Stabilized azithromycin compositions
TEVA PHARMA29 citations87
US6858652B2Feb 22, 2005
Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
TEVA PHARMA5 citations74
US6909004B2Jun 21, 2005
Method for the purification of lansoprazole
TEVA PHARMA5 citations73
US6861426B2Mar 1, 2005
Crystal forms of lamotrigine and processes for their preparations
TEVA PHARMA7 citations71
US7060837B2Jun 13, 2006
Method for the purification of lansoprazole
TEVA PHARMA3 citations62
US7022859B2Apr 4, 2006
Method for the purification of lansoprazole
TEVA PHARMA2 citations62
US7022881B2Apr 4, 2006
Sertraline hydrochloride polymorphs
TEVA PHARMA3 citations62
US6576764B2Jun 10, 2003
Synthesis and crystallization of piperazine ring-containing compounds
TEVA PHARMA2 citations62
US6545149B2Apr 8, 2003
Synthesis and crystallization of piperazine ring-containing compounds
TEVA PHARMA3 citations62
US7390807B2Jun 24, 2008
Crystal forms of lamotrigine and processes for their preparations
TEVA PHARMA3 citations60
US7462737B2Dec 9, 2008
Pregabalin free of isobutylglutaric acid and a process for preparation thereof
TEVA PHARMA2 citations58
US7683080B2Mar 23, 2010
Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
TEVA PHARMA0 citations51
US7678816B2Mar 16, 2010
Method of stabilizing lansoprazole
TEVA PHARMA0 citations51
US7622588B2Nov 24, 2009
Method for the purification of lansoprazole
TEVA PHARMA0 citations51
US5302741AApr 12, 1994
Optical resolution of threo-2-hydroxy-3-(2-aminophenylthio)-3-(4-methoxyphenyl)-propionic acid
TEVA PHARMA1 citations51
US7763749B2Jul 27, 2010
Method for the preparation of Pregabalin and salts thereof
TEVA PHARMA0 citations50
US7683177B2Mar 23, 2010
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
TEVA PHARMA0 citations50
US7678938B2Mar 16, 2010
Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
TEVA PHARMA0 citations50
US7619112B2Nov 17, 2009
Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
TEVA PHARMA0 citations50
TEVA GYOGYSZERGYAR ZARTKOERUEE
3 patentsUS7589128B2Sep 15, 2009
Process for preparation of amorphous form of a drug
TEVA GYOGYSZERGYAR ZARTKOERUEE6 citations57
US7452991B2Nov 18, 2008
Aztreonam β polymorph with very low residual solvent content
TEVA GYOGYSZERGYAR ZARTKOERUEE0 citations50
US7737177B2Jun 15, 2010
Processes for preparing crystalline and amorphous mupirocin calcium
TEVA GYOGYSZERGYAR ZARTKOERUEE0 citations44
TEVA GYOGYSZERGYAR ZARTKOERUEN
2 patentsUS7348429B2Mar 25, 2008
Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process
TEVA GYOGYSZERGYAR ZARTKOERUEN0 citations47
US7145017B2Dec 5, 2006
Preparation of Aztreonam
TEVA GYOGYSZERGYAR ZARTKOERUEN0 citations47